CVE:DOC

CloudMD Software & Services Competitors

C$1.95
-0.06 (-2.99 %)
(As of 04/19/2021 02:49 PM ET)
Add
Compare
Today's Range
C$1.94
Now: C$1.95
C$2.04
50-Day Range
C$1.76
MA: C$2.11
C$2.53
52-Week Range
C$0.50
Now: C$1.95
C$3.43
Volume725,423 shs
Average Volume1.72 million shs
Market CapitalizationC$385.70 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

CloudMD Software & Services (CVE:DOC) Vs. BUX, CHV, CSI, PHGI, PREV, and THCX

Should you be buying DOC stock or one of its competitors? Companies in the sector of "medical" are considered alternatives and competitors to CloudMD Software & Services, including (BUX) (BUX), (CHV) (CHV), (CSI) (CSI), (PHGI) (PHGI), (PREV) (PREV), and (THCX.V) (THCX).

(BUX) (CNSX:BUX) and CloudMD Software & Services (CVE:DOC) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for (BUX) and CloudMD Software & Services, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(BUX)0000N/A
CloudMD Software & Services01102.50

CloudMD Software & Services has a consensus target price of C$3.88, suggesting a potential upside of 96.70%.

Profitability

This table compares (BUX) and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(BUX)N/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A

Earnings & Valuation

This table compares (BUX) and CloudMD Software & Services' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(BUX)N/AN/AN/AN/AN/A
CloudMD Software & ServicesC$11.65 million33.45C$-17,801,550.00C($0.09)-21.89

(BUX) has higher earnings, but lower revenue than CloudMD Software & Services.

Summary

CloudMD Software & Services beats (BUX) on 2 of the 2 factors compared between the two stocks.

(CHV) (CNSX:CHV) and CloudMD Software & Services (CVE:DOC) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for (CHV) and CloudMD Software & Services, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
CloudMD Software & Services01102.50

CloudMD Software & Services has a consensus target price of C$3.88, suggesting a potential upside of 96.70%.

Profitability

This table compares (CHV) and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A

Earnings & Valuation

This table compares (CHV) and CloudMD Software & Services' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
CloudMD Software & ServicesC$11.65 million33.45C$-17,801,550.00C($0.09)-21.89

(CHV) has higher earnings, but lower revenue than CloudMD Software & Services.

Summary

CloudMD Software & Services beats (CHV) on 2 of the 2 factors compared between the two stocks.

(CSI) (CNSX:CSI) and CloudMD Software & Services (CVE:DOC) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for (CSI) and CloudMD Software & Services, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CSI)0000N/A
CloudMD Software & Services01102.50

CloudMD Software & Services has a consensus target price of C$3.88, suggesting a potential upside of 96.70%.

Profitability

This table compares (CSI) and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CSI)N/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A

Earnings & Valuation

This table compares (CSI) and CloudMD Software & Services' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CSI)N/AN/AN/AN/AN/A
CloudMD Software & ServicesC$11.65 million33.45C$-17,801,550.00C($0.09)-21.89

(CSI) has higher earnings, but lower revenue than CloudMD Software & Services.

Summary

CloudMD Software & Services beats (CSI) on 2 of the 2 factors compared between the two stocks.

(PHGI) (CNSX:PHGI) and CloudMD Software & Services (CVE:DOC) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for (PHGI) and CloudMD Software & Services, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PHGI)0000N/A
CloudMD Software & Services01102.50

CloudMD Software & Services has a consensus target price of C$3.88, suggesting a potential upside of 96.70%.

Earnings & Valuation

This table compares (PHGI) and CloudMD Software & Services' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PHGI)N/AN/AN/AN/AN/A
CloudMD Software & ServicesC$11.65 million33.45C$-17,801,550.00C($0.09)-21.89

(PHGI) has higher earnings, but lower revenue than CloudMD Software & Services.

Profitability

This table compares (PHGI) and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PHGI)N/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A

Summary

CloudMD Software & Services beats (PHGI) on 2 of the 2 factors compared between the two stocks.

CloudMD Software & Services (CVE:DOC) and (PREV) (CNSX:PREV) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Analyst Ratings

This is a breakdown of recent recommendations for CloudMD Software & Services and (PREV), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CloudMD Software & Services01102.50
(PREV)0000N/A

CloudMD Software & Services currently has a consensus price target of C$3.88, suggesting a potential upside of 96.70%.

Valuation and Earnings

This table compares CloudMD Software & Services and (PREV)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CloudMD Software & ServicesC$11.65 million33.45$-17,801,550.00C($0.09)-21.89
(PREV)N/AN/AN/AN/AN/A

(PREV) has lower revenue, but higher earnings than CloudMD Software & Services.

Profitability

This table compares CloudMD Software & Services and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CloudMD Software & ServicesN/AN/AN/A
(PREV)N/AN/AN/A

Summary

CloudMD Software & Services beats (PREV) on 2 of the 2 factors compared between the two stocks.

CloudMD Software & Services (CVE:DOC) and (THCX.V) (CVE:THCX) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Valuation and Earnings

This table compares CloudMD Software & Services and (THCX.V)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CloudMD Software & ServicesC$11.65 million33.45C$-17,801,550.00C($0.09)-21.89
(THCX.V)N/AN/AN/AN/AN/A

(THCX.V) has lower revenue, but higher earnings than CloudMD Software & Services.

Profitability

This table compares CloudMD Software & Services and (THCX.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CloudMD Software & ServicesN/AN/AN/A
(THCX.V)N/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations for CloudMD Software & Services and (THCX.V), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CloudMD Software & Services01102.50
(THCX.V)0000N/A

CloudMD Software & Services currently has a consensus price target of C$3.88, suggesting a potential upside of 96.70%. Given CloudMD Software & Services' higher possible upside, equities research analysts plainly believe CloudMD Software & Services is more favorable than (THCX.V).

Summary

CloudMD Software & Services beats (THCX.V) on 3 of the 3 factors compared between the two stocks.

pixel
Ad RSF MGMT
Could This Be The Apple Of Funcitonal Superfoods?
With explosive revenue potential + products hitting Rite Aid this is THE company to watch!

CloudMD Software & Services Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
BUX
(BUX)
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
CSI
(CSI)
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
PHGI
(PHGI)
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
THCX
(THCX.V)
0.6$5.30-6.2%C$0.00N/A0.00High Trading Volume
IME
12144
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
COM
138267 (COM.TO)
0.5$2.95-2.7%C$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
BAMM
28896
0.5N/AN/A$0.00N/A0.00High Trading Volume
GLH
31444
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ACG
438280
0.6N/AN/AC$0.00N/A0.00Gap Down
HC
815446
0.5N/AN/A$0.00N/A0.00Gap Down
ATT
Abattis Bioceuticals
0.5N/AN/AC$0.00N/A0.00Gap Down
AGRA
Agraflora Organics International
1.4N/AN/A$0.00N/A0.00High Trading Volume
AMS
American Shared Hospital Services
0.6N/AN/A$0.00N/A0.00High Trading Volume
BE
Beleave
0.6N/AN/AC$0.00N/A0.00High Trading Volume
BE
Beleave
0.6N/AN/A$0.00N/A0.00High Trading Volume
BIO
Bio-Rad Laboratories
0.5N/AN/A$0.00N/A0.00High Trading Volume
BBM
Blueberries Medical
0.6N/AN/A$0.00N/A0.00High Trading Volume
CXV
BLVD Centers
0.5$0.07-100.0%C$0.00N/A0.00Gap Down
BLO
Cannabix Technologies
0.5N/AN/AC$0.00N/A0.00News Coverage
Gap Up
LOVE
Cannara Biotech
0.7N/AN/A$0.00N/A0.00High Trading Volume
CRL
Charles River Laboratories International
0.5N/AN/A$0.00N/A0.00Gap Up
CALI
China Auto Logistics
1.3N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
EHC
Encompass Health
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
PLUS
ePlus
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
MJ
ETFMG Alternative Harvest ETF
0.5N/AN/A$0.00N/A0.00News Coverage
Gap Down
BOSS
Global X Founder-Run Companies ETF
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
GRIN
Grindrod Shipping
1.7N/AN/A$0.00N/A0.00High Trading Volume
HALO
Halozyme Therapeutics
1.3$47.00-1.3%C$0.00C$267.59 million51.65
LTY
Liberty Biopharma
0.6$2.00-100.0%C$0.00N/A-12.66Gap Down
LHS
Liberty Health Sciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
LIB
Liberty Leaf
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
LDS
Lifestyle Delivery Systems
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
MMJ
Matica Enterprises
0.5N/AN/AC$0.00N/A0.00High Trading Volume
MMEN
Medmen Enterprises
0.6N/AN/A$0.00N/A0.00High Trading Volume
PULL
Mind Cure Health
1.7N/AN/A$0.00N/A0.00High Trading Volume
ORTH
Ortho Regenerative Technologies
0.5N/AN/A$0.00N/A0.00High Trading Volume
RQB
Ravenquest Biomed
0.6N/AN/A$0.00N/A0.00High Trading Volume
SCYB
Scythian Biosciences
0.5$3.49-6.3%C$0.00N/A0.00High Trading Volume
SENS
Senseonics
0.0N/AN/A$0.00N/A0.00High Trading Volume
Smith & Nephew logo
SNN
Smith & Nephew
0.6N/AN/A$0.00N/A0.00
TGIF
SoFi Weekly Income ETF
0.6N/AN/A$0.00N/A0.00High Trading Volume
SPR
Spirit AeroSystems
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
THC
Tenet Healthcare
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
THC
Tenet Healthcare
1.7N/AN/AC$0.00C$17.64 billion0.00Upcoming Earnings
High Trading Volume
Valeant Pharmaceuticals International logo
VRX
Valeant Pharmaceuticals International
0.5$30.80-3.4%C$0.00N/A0.00
BUZZ
VanEck Vectors Social Sentiment ETF
1.0N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.